Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells Stefanie KoristkaPauline Ziller-WalterMichael P. Bachmann Original Article Open access 14 August 2019 Pages: 1401 - 1415
Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone David Rafei-ShamsabadiSaskia LehrFrank Meiss Original Article 17 August 2019 Pages: 1417 - 1428
A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice Yao XuXinrong ZhangJuan Zhang Original Article 19 August 2019 Pages: 1429 - 1441
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer Mohamed BadrKorinna JöhrensJan Budczies Original Article 23 August 2019 Pages: 1443 - 1454
Melanoma-conditioned medium promotes cytotoxic immune responses by murine bone marrow-derived monocytes despite their expression of ‘M2’ markers Liam Friel TrembleAnne C. MoorePatrick F. Forde Original Article 23 August 2019 Pages: 1455 - 1465
Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials Lijun LiangYixuan WenXiaodong Jiang Original Article 27 August 2019 Pages: 1467 - 1477
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation Luciano CastielloAlessandra ZeviniJohn Hiscott Original Article 28 August 2019 Pages: 1479 - 1492
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma Jason RoszikEttai MarkovitsRaya Leibowitz-Amit Original Article 09 September 2019 Pages: 1493 - 1500
Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer Yuping D. LiJonathan B. LamanoOrin Bloch Original Article 05 September 2019 Pages: 1501 - 1513
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature Emily HinchcliffCherie PaquetteAmir Jazaeri Original Article 12 September 2019 Pages: 1515 - 1526
Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer Danyang SunJunxun MaYi Hu Original Article Open access 18 September 2019 Pages: 1527 - 1535
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer Fabio GrizziAngelo CastelloEgesta Lopci Original Article 03 September 2019 Pages: 1537 - 1545
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients Benjamin WeideThomas EigentlerClaus Garbe Clinical Trial Report 03 September 2019 Pages: 1547 - 1559
